The rising geriatric population and increasing prevalence of cardiovascular diseases has resulted in an increase in cases of atrial fibrillation. Thus, creating demand for atrial fibrillation devices. According to research & publications, there are about 3 million people worldwide with pacemakers, and each year 600,000 pacemakers are implanted. Among them, the majority of patients are aged 60 years or older. Furthermore, an increasingly stressful lifestyle is also a cause of arrhythmia and in long run, it is responsible for the increasing cases of atrial fibrillation and increases the market size of atrial fibrillation devices.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22580
According to UnivDatos Market Insights (UMI)’ research report “Global Atrial Fibrillation Devices Market Analysis, 2021”, the atrial fibrillation devices market is projected to grow at a CAGR of ~11% during 2021-27F. Deteriorating health coupled with the rising cost of medical treatment is one of the major reasons for the development of advanced diagnostic and treatment devices, thus driving the atrial fibrillation devices market globally.
Based on the Product, the market is segmented into laboratory devices, ablation catheters, diagnostic catheters, and access devices. The ablation catheters are expected to witness significant market share in the atrial fibrillation device market. It is mainly due to the increasing demand for minimally invasive and painless procedures. Furthermore, the rapid advancements in technology also drive the market segment in the market. For instance, in June 2021, Acutus Medical launched AcQBlate Force Sensing Ablation System in Europe. AcQBlate FORCE shows physicians, in real-time, how much contact is being applied to the heart during ablation procedures.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22580
Based on the end-users, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals are expected to witness lucrative growth during the forecast period. This is mainly due to the presence of well-qualified professionals and their specialization in the treatment of multiple diseases. Furthermore, the rising number of heart diseases and the presence of diagnostic centers and other facilities under the same roof is responsible for the segmental growth in the atrial fibrillation device market.
North America to Grab Lion’s Share, and witnessed Explicit Growth
Based on the region, North America dominated the global atrial fibrillation devices market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the well-established market players and frequent product launches. North America is expected to skyrocket with a robust CAGR during the forecast period, as stated in UnivDatos Market Insights (UMI)’ research report “Global Atrial Fibrillation Devices Market Analysis, 2021”.
For more informative information, please visit us – https://univdatos.com/report/atrial-fibrillation-devices-market/
According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Atrial Fibrillation Devices market include Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical Inc., Medtronic plc, Abbott Laboratories, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc., among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.
“Global Atrial Fibrillation Devices Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for atrial fibrillation device providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.
For more informative information, please visit us – https://univdatos.com/report/atrial-fibrillation-devices-market/
Market Segmentation:
1. By Product (Laboratory Devices{3D Mapping Systems, RF Ablation Systems, Cardiac, Stimulators, and Others}, Ablation Catheters{ RF Ablation, Laser, and Others}, Diagnostic Catheters{Conventional, Advanced, Ultrasound}, and Access Devices)
2. By End-users (Hospitals, Ambulatory Surgical Centers, and Others)
3. By Region (North America, Europe, Asia-Pacific, Rest of the World)
4. By Company (Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical Inc., Medtronic plc, Abbott Laboratories, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc.)
Key questions answered in the study:
1. What are the current and future trends of the atrial fibrillation devices industry?
2. How the industry has been evolving in terms of product and end-users?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the atrial fibrillation devices industry?
5. What is the customer orientation, purchase behavior, and expectations from the atrial fibrillation devices firms across various regions?
Table of Content –
1. MARKET INTRODUCTION
2. RESEARCH METHODOLOGY OR ASSUMPTION
3. MARKET SYNOPSIS
4. EXECUTIVE SUMMARY
5. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET COVID-19 IMPACT
6. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET REVENUE, 2019-2027F
7. MARKET INSIGHTS BY PRODUCT
8. MARKET INSIGHTS BY END-USERS
9. MARKET INSIGHTS BY REGION
10. ATRIAL FIBRILLATION DEVICES MARKET DYNAMICS
11. ATRIAL FIBRILLATION DEVICES MARKET OPPORTUNITIES
12. ATRIAL FIBRILLATION DEVICES MARKET TRENDS
13. LEGAL & REGULATORY FRAMEWORK
14. DEMAND AND SUPPLY-SIDE ANALYSIS
15. VALUE CHAIN ANALYSIS
16. COMPETITIVE SCENARIO
17. COMPANY PROFILED
18. DISCLAIMER
Browse Other Related Research Reports from UnivDatos Market Insights
· Venous Stents Market to exceed US$ 2 Billion by 2027 Globally |CAGR: 9%|
· Oncology Therapeutics Market to exceed US$ 247.5 Billion by 2027 Globally |CAGR: 8.2%|
· Neuromodulation Devices Market to exceed US$ 11.7 Billion by 2027 Globally |CAGR: 8.4%|
· Digital Health Market to exceed US$ 746 Billion by 2027 Globally | CAGR: 26.3% |
About Us:
UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.
Contact us:
UnivDatos Market Insights (UMI)
Email: sales@univdatos.com
Ph: +91 7838604911